Almost one year after Biogen forged a collaboration with Sage Therapeutics worth $1.52 billion, the development deal for the experimental major depressive disorder treatment zuranolone is bearing fruit that will support an expected rolling New Drug Application during 2022.
If you are not happy with the results below please do another search
50 search results for:
Janssen Pharmaceutical and Amgen received another regulatory win for Darzalex Faspro (daratumumab and hyaluronidase-fihj) as the U.S. Food and Drug Administration approved the drug in combination with Amgen’s Kyprolis (carfilzomib) and dexamethasone for the treatment of adults with relapsed or refractory multiple myeloma who have received one to three prior lines of therapy.
The United States ordered airlines to hand over the names of passengers from southern African countries hit by the Omicron Covid-19 variant and other countries tightened their borders as a European leader urged people to “prepare for the worst.”
Vertex Pharmaceuticals reported the company’s Phase II proof-of-concept trial of VX-147 in patients with APOL1-mediated focal segmental glomerulosclerosis (FSGS), with the drug hitting a statistically significant and clinically meaningful decrease of 47.6% in the urine protein to creatinine ratio (UPCR) at Week 13 compared to baseline.
Sanofi is expanding the company’s research into skin therapies after agreeing to acquire the Australian firm Origimm Biotechnology, which specializes in treatments for various types of skin diseases.
The White House said on December 1 the U.S. Department of Justice “will vigorously defend” the government’s authority to promote its vaccine requirement in federal contracting after courts blocked the Biden administration from enforcing two vaccine mandates.
Jennie Fischette, who joined Omnicom Health Group in 2015 to launch DDB Health as its US President, was elevated to the role of CEO of DDB Health Network.
The World Health Organization (WHO) agreed on December 1 to launch negotiations on an international pact to prevent and control future pandemics at a time when the world is gearing up to battle the new Omicron variant of coronavirus.
The Omicron coronavirus variant detected in southern Africa could be the most likely candidate to displace the highly contagious Delta variant, the director of South Africa’s communicable disease institute said on November 30.
A panel of expert advisers to the U.S. Food and Drug Administration on November 30 narrowly voted to recommend the regulatory agency authorize Merck & Co.’s antiviral pill to treat Covid-19.